Aldena Therapeutics
Latest round
- Series A
Last raised
- Mar 2023
Total raised
- $30M
Investors
- 1
About Aldena Therapeutics
Based in Massachusetts, US, and founded in 2021, Aldena Therapeutics Inc. operates as a biotechnology research company that offers siRNA-based therapies for dermatological indications. The company was founded by John Harris, Mark Prausnitz and Andrew Tadros. In March 2023, Aldena Therapeutics Inc. The company offers siRNA-based treatments for patients suffering from dermatological diseases.
Who invested in Aldena Therapeutics
1 investor across 1 round
See all investors in Aldena Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Mar 16, 2023
Amount
$30M
Investors
Questions about Aldena Therapeutics
Who invested in Aldena Therapeutics?
Aldena Therapeutics has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Aldena Therapeutics raised?
Aldena Therapeutics has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Aldena Therapeutics last raise money?
Aldena Therapeutics's most recent round on record is a Series A, in Mar 2023.
What does Aldena Therapeutics do?
Based in Massachusetts, US, and founded in 2021, Aldena Therapeutics Inc.
Where is Aldena Therapeutics headquartered?
Aldena Therapeutics is headquartered in Boston, US.
Which VCs invest in companies like Aldena Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Aldena Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Aldena Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.